Literature DB >> 10211025

Cerebrospinal fluid concentrations of propofol during anaesthesia in humans.

O Engdahl1, M Abrahams, A Björnsson, M Vegfors, B Norlander, J Ahlner, C Eintrei.   

Abstract

The concentration of propofol in and surrounding the human brain during propofol anaesthesia is unknown. We measured simultaneously the concentration of propofol in cerebrospinal fluid (CSF) from an indwelling intraventricular catheter and the concentration in arterial blood in five neurosurgical patients before, during induction (at 2.5 and 5 min) and during a maintenance propofol infusion (at 15 and 30 min). After induction of anaesthesia with propofol 2 mg kg-1, anaesthesia was maintained with an infusion of 8 mg kg-1 h-1 for 15 min and then reduced to 6 mg kg-1 h-1. The plasma concentration of propofol increased rapidly during induction and reached a plateau concentration of mean 2.24 (SD 0.66) micrograms ml-1 after 5 min. The concentration of propofol in CSF showed a slower increase during induction and remained almost constant at 35.5 (19.6) ng ml-1 at 15-30 min after induction. The CSF concentration of propofol that we measured was 1.6% of the plasma concentration and consistent with the high protein binding of the drug in plasma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10211025     DOI: 10.1093/bja/81.6.957

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  14 in total

Review 1.  Anatomical-physiological approaches in pharmacokinetics and pharmacodynamics.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Propofol's effects on phagocytosis, proliferation, nitrate production, and cytokine secretion in pressure-stimulated microglial cells.

Authors:  Guangxiang Yu; Michael Dymond; Lisi Yuan; Lakshmi S Chaturvedi; Hiroe Shiratsuchi; Srinivasan Durairaj; H Michael Marsh; Marc D Basson
Journal:  Surgery       Date:  2011-06-15       Impact factor: 3.982

3.  Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.

Authors:  Ashraf A Dahaba; Zhaoyang Xiao; Xiaoling Zhu; Hailong Dong; Lize Xiong; Peter Rehak; Sieglinde Zelzer; Kun Wang; Gilbert Reibnegger
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-25       Impact factor: 2.745

4.  Cerebrospinal fluid and plasma propofol concentration during total intravenous anaesthesia of patients undergoing elective intracranial tumor removal.

Authors:  Wei Luo; Yu-Hong Li; Jian-Jun Yang; Jie Tian; Jian-Guo Xu
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

5.  HCN1 channels as targets for anesthetic and nonanesthetic propofol analogs in the amelioration of mechanical and thermal hyperalgesia in a mouse model of neuropathic pain.

Authors:  Gareth R Tibbs; Thomas J Rowley; R Lea Sanford; Karl F Herold; Alex Proekt; Hugh C Hemmings; Olaf S Andersen; Peter A Goldstein; Pamela D Flood
Journal:  J Pharmacol Exp Ther       Date:  2013-04-02       Impact factor: 4.030

6.  Free and bound propofol concentrations in human cerebrospinal fluid.

Authors:  Andrzej L Dawidowicz; Rafal Kalitynski; Anna Fijalkowska
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

7.  Propofol induces MAPK/ERK cascade dependant expression of cFos and Egr-1 in rat hippocampal slices.

Authors:  Srivatsan Kidambi; Joel Yarmush; Yevgeny Berdichevsky; Sangeetha Kamath; Wayne Fong; Joseph Schianodicola
Journal:  BMC Res Notes       Date:  2010-07-17

8.  Propofol induces ERK-dependant expression of c-Fos and Egr-1 in neuronal cells.

Authors:  Srivatsan Kidambi; Joel Yarmush; Wayne Fong; Sangeetha Kamath; Joseph Schianodicola; Yaakov Nahmias
Journal:  Neuroreport       Date:  2009-05-06       Impact factor: 1.837

9.  Propofol directly increases tau phosphorylation.

Authors:  Robert A Whittington; László Virág; François Marcouiller; Marie-Amélie Papon; Noura B El Khoury; Carl Julien; Françoise Morin; Charles W Emala; Emmanuel Planel
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

10.  Propofol: neuroprotection in an in vitro model of traumatic brain injury.

Authors:  Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Steffen Rex; Mark Coburn
Journal:  Crit Care       Date:  2009-04-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.